iNtRON Biotechnology

인트론바이오 · 048530

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$60.8M (₩83.9B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$4.2M

▼ −10.6% YoY

Operating profit · FY2025

−US$5.7M

Loss widened

Net income · FY2025

−US$6.5M

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$6.9M(₩9.6B)	US$4.7M(₩6.4B)	US$4.2M(₩5.7B)
Operating profit	−US$2.4M(−₩3.3B)	−US$3.8M(−₩5.2B)	−US$5.7M(−₩7.9B)
Net income	−US$7M(−₩9.7B)	−US$1.9M(−₩2.6B)	−US$6.5M(−₩9B)

Revenue

Operating profit

Net income

ROE

-12.8%

Debt/Eq

6.4%

Op. margin

-137.7%

Net margin

-156.1%

Rev. YoY

▼ −10.6%

Interactive price history isn't here yet. Would you use it?